UK biotech Ternary raises £3.6m to scale AI platform for next-generation drugs

by Energy And Markets Now

56 years ago

Energy And Markets Now

Home / Economy / UK biotech Ternary raises £3.6m to scale AI platform for next-generation drugs

UK biotech Ternary raises £3.6m to scale AI platform for next-generation drugs

by Energy And Markets Now

March 16, 2026

Economy

[#item_full_content]

Disclaimer: SecretsOfRichDads.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Energy And Markets Now

UK biotech Ternary raises £3.6m to scale AI platform for next-generation drugs

NCP faces administration as Britain’s largest car park operator files court notice

British expats fleeing Middle East conflict fear unexpected UK tax bills

Maven backs digital investigations platform Chorus with £15m investment to drive AI expansion